Posted in | News | Medical Sensor | Gas Sensor

Report on Pulse Oximeter Performance by Non Medical

Nonin Medical, Inc., the inventor of finger pulse oximeters and a leader in noninvasive medical monitoring, today released a Pulse Oximetry Special Report for durable medical equipment (DME) providers at Booth #953 at Medtrade 2012 in Atlanta. Medtrade is the largest home medical equipment tradeshow in the United States.

The report, "Too Good to be True? Three Ways Cheap Pulse Oximeters May be Short-changing Your Patients and Profits," is designed to help DME home respiratory monitoring providers understand that not all pulse oximeters perform alike, quality does matter, and reliable product performance can provide a competitive advantage. The results of the report are based on clinical data findings, customer feedback and competitive comparison testing collected by Nonin Medical over 26 years.

"With the influx of imported pulse oximeters into the homecare market, and the belief that all pulse oximeters perform alike, it's reasonable for DME providers to think that they are getting the best value from cheap or free oximeters," said Bill Wood, Homecare Key Accounts Manager, Nonin Medical. "However, our pulse oximeter customers have found that when they have opted for these types of oximeters, in many cases, they often ended up paying a hidden price in terms of missed revenue opportunities, lost productivity, continuous inventory replacement, and patient dissatisfaction due to broken or malfunctioning pulse oximeters.

"This hidden price can seriously erode a DME's bottom line and affect future revenues, not to mention compromise patient safety and outcomes," Wood said. The answer, he added, lies in understanding product performance differences and knowing what to look for in pulse oximeters for home use — tips outlined in Nonin's DME Pulse Oximetry Special Report.

"Nonin's Special Report provides a comprehensive checklist and clinical resources that DMEs can use to evaluate pulse oximeters objectively before purchasing," Wood said. "It may help DMEs avoid being penny wise and pound foolish in this cost-sensitive environment," he said.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.